Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yolande Pijnenburg

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Nature Communications|January 29, 2025
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatmentKatharina Bolsewig, Eline A J Willemse, Pascual Sánchez-Juan, et al.
Nature Aging|March 12, 2026
Microglia protein profiles in CSF across Alzheimer's disease clinical stagesElena-Raluca Blujdea, Pieter van Bokhoven, Pamela V Martino-Adami, et al.
Nature Medicine|April 15, 2026
An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degenerationMadison I J Honey, Yanaika S Hok-A-Hin, Elisabeth H Thijssen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 23, 2025
Diagnostic performance of plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias: An international multi-center studyJames D Doecke, Giovanni Bellomo, Lisa Vermunt, et al.
The Lancet. Neurology|January 24, 2024
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysisMarianne Chapleau, Renaud La Joie, Keir Yong, et al.
Human Brain Mapping|March 10, 2023
Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementiaAurélie Bussy, Jake P Levy, Tristin Best, et al.
Brain : a Journal of Neurology|March 5, 2020
Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disordersSimon Ducharme, Annemiek Dols, Robert Laforce, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 6, 2017
Consensus classification of posterior cortical atrophySebastian J Crutch, Jonathan M Schott, Gil D Rabinovici, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 4, 2023
Gaps in clinical research in frontotemporal dementia: A call for diversity and disparities-focused researchSanne Franzen, Karen Nuytemans, Renelle Bourdage, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2024
Gaps in biomedical research in frontotemporal dementia: A call for diversity and disparities focused researchKaren Nuytemans, Sanne Franzen, Iris J Broce, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Nature Communications|January 29, 2025
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatmentKatharina Bolsewig, Eline A J Willemse, Pascual Sánchez-Juan, et al.
Nature Aging|March 12, 2026
Microglia protein profiles in CSF across Alzheimer's disease clinical stagesElena-Raluca Blujdea, Pieter van Bokhoven, Pamela V Martino-Adami, et al.
Nature Medicine|April 15, 2026
An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degenerationMadison I J Honey, Yanaika S Hok-A-Hin, Elisabeth H Thijssen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 23, 2025
Diagnostic performance of plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias: An international multi-center studyJames D Doecke, Giovanni Bellomo, Lisa Vermunt, et al.
The Lancet. Neurology|January 24, 2024
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysisMarianne Chapleau, Renaud La Joie, Keir Yong, et al.
Human Brain Mapping|March 10, 2023
Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementiaAurélie Bussy, Jake P Levy, Tristin Best, et al.
Brain : a Journal of Neurology|March 5, 2020
Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disordersSimon Ducharme, Annemiek Dols, Robert Laforce, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 6, 2017
Consensus classification of posterior cortical atrophySebastian J Crutch, Jonathan M Schott, Gil D Rabinovici, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 4, 2023
Gaps in clinical research in frontotemporal dementia: A call for diversity and disparities-focused researchSanne Franzen, Karen Nuytemans, Renelle Bourdage, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2024
Gaps in biomedical research in frontotemporal dementia: A call for diversity and disparities focused researchKaren Nuytemans, Sanne Franzen, Iris J Broce, et al.
Pageof 8